Introduction
The papillary subtype of renal cell carcinoma (RCC) accounts for about 10% of all kidney tumours. In general, the diagnosis of papillary RCC is based on cytological and growth pattern characteristics (Weiss et al., 1995; Amin et al., 1997) . However, renal tumours exhibit a heterogeneous morphology and their histological features can change during tumour progression (Kovacs, 1993a; Lager et al., 1995; Wilhelm et al., 1995) . Molecular cytogenetic analysis allows the distinction of papillary RCC from other RCCs based on speci®c chromosomal anomalies that persist throughout tumour progression (Kovacs, 1993b) . Indeed, the most common non papillary subtype, clear cell renal carcinoma, is characterized by deletions in chromosome arm 3p, whereas the 3p region is intact in papillary RCC. In addition, the latter exhibits an increase in chromosome number typically including chromosomes 7 and 17. These anomalies are also found in early renal lesions such as adenomas, suggesting that they could be involved in tumour initiation. The evolution of papillary tumours is characterized by additional polysomy of chromosomes 8, 12, 16, and 20 (Kovacs et al., 1991; Kovacs, 1993b) .
Trisomy 7 is the most frequent cytogenetic abnormality in early as well as advanced stages of papillary RCCs, suggesting that a gene (or genes) located on chromosome 7 plays a role in the pathogenesis of these tumours. One approach to pinpoint such a gene consists in seeking tumours that have retained only a limited region of chromosome 7 as the sole overrepresented genetic material from this chromosome. Reduction of the size of the chromosomal region bearing a candidate gene is more likely to occur in advanced tumours as a consequence of chromosome rearrangements during tumour progression. We have previously reported the molecular cytogenetic characterization of four sporadic metastatic papillary RCCs and of their counterparts xenografted in severe combined immunode®cient (SCID) mice. Among them, two tumours and their corresponding xenografts were found to harbour one to four small derivative chromosomes (hereafter designated`minichromosomes'). In both cases, all the minichromosomes were composed of small fragments derived solely from chromosome 7. Moreover, the der(7) minichromosomes from both tumours appeared to only have in common a small region located within band 7q31 (Glukhova et al., 1998) .
In the present work, we have re®ned the location of the unique region of overlap between the two types of minichromosomes to the junction of bands 7q31.2 and 7q31.3 and shown that it contains the MET protooncogene. Tumour cell DNA and RNA were analysed by Southern and Northern blotting to assess the MET gene copy number and mRNA accumulation level, respectively. In order to determine whether these two parameters might evolve during tumour progression, a comparison was made between initial tumours and their xenografted counterparts serially transplanted into SCID mice, the latter exhibiting a higher nuclear grade as de®ned by Fuhrman et al. (1982) .
Results

Characterization of the 7q31 region carried on minichromosomes
We have previously reported that the karyotype of the cells from the three tumours RCC-1, RCC-43 and RCC-47 (nuclear grade 1 ± 2) and from the corresponding xenografted tumours RCC-1 P6, RCC-43 P5 and RCC-47 P3 (grade 3 ± 4), serially transplanted into SCID mice for six, ®ve or three passages, respectively, exhibited a total or partial polysomy of chromosome 7 (Glukhova et al., 1998 ; see Materials and methods for tumour nomenclature). RCC-1 and RCC-1 P6 exhibited one or two t(7;2;7) chromosomes per cell and this derivative chromosome was shown to contain a duplicated 7q21-qter region. RCC-43 and RCC-47, as well as RCC-43 P5 and RCC-47 P3, had additional material from chromosome 7 associated with minichromosomes. Molecular cytogenetic analysis indicated that a chromosomal region centred on band 7q31 was shared by the der(7) minichromosomes from both tumours (Glukhova et al., 1998) .
To con®rm these observations, reverse painting on chromosomes from normal cells was carried out by simultaneous hybridization with two probes prepared from the microdissected minichromosomes of the two xenografted tumours RCC-43 P5 and RCC-47 P3 and stained with rhodamine and¯uorescein, respectively (see Materials and methods). Fluorescence microscopic examination showed the speci®c regional staining of only chromosome 7 previously observed with each individual probe (Glukhova et al., 1998) , but disclosed, in addition, the presence of a small overlapping area (yellow signal) at the junction of one of the RCC-43 P5-speci®c red signals (7q31.2 ± q31.3) and of one of the RCC-47 P3-speci®c green signals (7q31.1 ± q31.3) (Figure 1 ).
Refined mapping of the overlapping 7q31 subregion associated with the minichromosomes
With the aim of mapping more precisely the region of overlap,¯uorescent in situ hybridization (FISH) analyses were carried out, using as probes two nonchimeric and nonoverlapping yeast arti®cial chromosomes (YACs), 746H5 and 880B6 that target the 7q31.2 ± q31.3 and 7q31.3 ± q32.1 regions, respectively. As a control, they were ®rst hybridized to the RCC-1 tumour cells. The expected number of¯uorescent signals per metaphase were observed with each of them: one twin-spot on each of the two normal chromosomes 7 and two twin-spots on each t(7;2;7) derivative chromosome (data not shown). For both RCC-43 and RCC-47 P3, 746H5-speci®c spots were found, besides the two normal chromosomes 7, on all of the minichromosomes. The number of associated signals indicated that each minichromosome contributed about two copies of the 746H5-hybridizing region per cell (Figure 2 ). The 880B6 probe was only able to label the two normal chromosomes 7, indicating that the region this YAC corresponds to is not present in the minichromosomes from RCC-43 and RCC-47 P3.
Southern blot determination of the MET gene copy number in RCC tumour cells
In view of the presence of MET sequences in YAC 746H5 (see Materials and methods), we chose to measure directly the copy number of the MET gene by Southern blot analysis of the DNA extracted from the cells of both the RCC-43 and RCC-47 tumours and of the RCC47 P3 xenografted tumour, using two dierent probes. (Cells from the RCC-43 P5 xenografted tumour could not be studied because of their inability to grow into mass culture). In order to validate the results obtained, DNA from the cells of the RCC-1 tumour and of the RCC-1 P6 xenografted tumour (which harbour a number of MET-bearing chromosome 7 long arms that can be precisely counted) was analysed in parallel, together with DNA from RCC-41 P2 cells, derived from a xenografted undierentiated RCC that contains, on average, close to two normal chromosomes 7. DNA from ICIG-7 Figure 1 Detection of an overlapping 7q31 subregion common to the minichromosomes of RCC-43 P5 and RCC-47 P3. Reverse painting was carried out by simultaneous hybridization to normal cell metaphases of two probes generated from the microdissected minichromosomes of the xenografted tumours RCC-43 P5 and RCC-47 P3 and stained with two dierent¯uorochromes: rhodamine and¯uorescein, respectively. Photographs of the same normal chromosome 7, taken with dierent UV-light ®lters, are shown. From top to bottom: 4',6-diamidino-2-phenylindole (DAPI) counterstaining; double-staining with the two minichromosome-speci®c probes showing the region of overlap at the border of bands 7q31.2 and 7q31.3 (yellow signal); single-staining with the RCC-43 P5 minichromosome-speci®c probe (red signals); single-staining with the RCC-47 P3 minichromosome-speci®c probe (green signals); diagram of chromosome 7 showing the location of the overlapping region cells, normal human ®broblasts that are perfectly diploid, was used as a standard to calculate the relative copy number of the MET gene. Each Southern blot contained duplicate samples of each cell DNA to check for any variation in the eciency of DNA transfer and/or hybridization. Two genomic DNA fragments from the human MET locus were used as probes: pmetD and pmetH (see Materials and methods). Since all of the cells examined were disomic for chromosome 11, the BK4 genomic probe speci®c for the FGF-3 gene located at chromosomal band 11q13 was used to yield positive signals that could serve as a reference to correct for variations in DNA loading. Labelling of the probes was carried out on a mixture of equivalent amounts of either MET fragment and of the FGF-3 BK4 fragment. Indeed, both genes could be simultaneously analysed on the same blot due to the large dierence in size of the EcoRI fragments hybridizing to the MET probes (1.2 kb for pmetD and 2.3 kb for pmetH) and that hybridizing to the FGF-3 probe (9.8 kb). An illustration of the results obtained with probe pmetD is shown in Figure 3 . For the purpose of con®rming the data obtained with the two MET probes, the analysis was extended to another gene belonging to the 7q31 region, in the vicinity of the MET locus. The blot formerly probed with pmetD was stripped and rehybridized with the genomic probe H2.3A speci®c for the WNT-2 gene (Figure 3 ), which is located at a distance of about 500 kb, telomeric to the MET gene (see Lin et al., 1996) . Table 1 summarizes the results obtained from the quantitation of the signal intensities of the fragments hybridizing with the two MET probes, as well as the WNT-2 probe. The copy numbers determined with the three probes were in close agreement for each of the tumours examined. Moreover, the results were consistent with the average copy number of the 7q31 region estimated from the number of spots per cell detected in the ®ve tumour cell populations analysed by FISH, using YAC 746H5 as a probe (Table 1 ). These data indicate that both the MET and WNT-2 genes belong to the short overrepresented 7q31 region shared by the minichromosomes from RCC-43 and RCC-47. It has to be noted that gene copy numbers were not found to be signi®cantly dierent between the two xenografted tumours RCC-1 P6 and RCC-47 P3 and their corresponding initial tumours RCC-1 and RCC-47, respectively, despite their higher nuclear grade.
Expression of the MET gene in RCC tumour cells
On the basis of the increased number of copies of the MET gene demonstrated above, it was of interest to analyse its expression by Northern blotting in the cells from our panel of papillary RCCs. As cultured epithelial cells derived from normal kidney proximal tubules (from which papillary renal tumours are presumed to originate) were not available to us, we used, as a control, RNA prepared from RCC-41 P2 cells which have, on average, close to two normal chromosomes 7 (see Table 1 ). Hybridization was carried out with a MET cDNA fragment probe. A major mRNA species of about 8 kb was detected in the cells from all of the tumours analysed ( Figure 4 and data not shown). The size of this mRNA is in agreement with that of the transcript previously shown to encode the 190 kDa MET heterodimeric receptor In each of the two representative metaphases shown, the two normal chromosomes 7 can be identi®ed by the presence of a centromere-speci®c red spot and a pair of green signals corresponding to YAC 746H5 (7q31.2 ± q31.3). All the minichromosomes display red-stained centromeric sequences and, generally, two pairs of green signals (Lin et al., 1998) . Quantitation of the signals indicated that the MET gene was overexpressed at a 9 ± 12-fold higher level in the cells that harbour extra-copies of the gene, as compared to the cells from the control RCC-41 P2 tumour (see Figure 4 , bottom of the upper panel). Only a low level of MET expression, similar to that in RCC-41 P2, was also detected in several tumorigenic and non-tumorigenic clones derived from the unrelated SW613-S human colon carcinoma cell line (Galdemard et al., 1995;  data not shown). Altogether, these results indicate that MET is the gene selected for in the short 7q31 region common to both the RCC-43 and RCC-47 minichromosomes and whose overexpression played a role in the development of these tumours. The mRNA accumulation level does not change in the cells from the two xenografted tumours RCC-1 P6 and RCC-47 P3 compared with those from the corresponding initial tumours RCC-1 and RCC-47, in agreement with the stability of the MET gene copy number noted above.
Discussion
Previous cytogenetic studies have led to the observation that papillary RCCs display a recurrent combination of alterations of three chromosomes: trisomy or tetrasomy 7 as the most frequent genetic event followed by trisomy 17 and loss of the Y chromosome (Kovacs et al., 1991; Kovacs, 1993b; Bentz et al., 1996) . Polysomy of a chromosome may cause an imbalance in a gene (or genes), leading to its overexpression and playing an early role in tumour development. Delineation of the minimal chromosomal region required for the maintenance of the tumorigenic phenotype aords a means to identify the gene involved. However, in most cases described to date, the whole chromosome 7 is found duplicated. A partial duplication of the chromosomal region 7q21 ± q35 had been previously described in one out of four tumours from a patient with hereditary papillary RCC (Bernues et al., 1995) . The tumours investigated here also exhibit a gain of genetic material derived from dierent regions of chromosome 7. RCC-1 and RCC-1 P6 cells have additional copies of the 7q21-qter region carried in duplicate on a t(7;2;7) derivative chromosome. RCC-43 and RCC-47 P3 harbour one to three der(7) minichromosomes as the sole overexpressed material from chromosome 7. Previous molecular cytogenetic analysis had shown that the minimal overrepresented genomic region common to the minichromosomes from both tumours was centred on band 7q31 (Glukhova et al., 1998) .
In the present work, we have re®ned the location of the overlapping region to the junction of bands 7q31.2 and 7q31.3 by means of simultaneous reverse painting using two probes prepared from the microdissected minichromosomes of each tumour and detected with dierent¯uorochromes. Of the two YACs chosen as probes in FISH analyses based on their map location to bands 7q31 ± q32, 746H5 was found to target the region of overlap. In agreement with the contig physical map published by Lin et al. (1996) on which this YAC is shown to overlap the MET protooncogene locus, the presence of MET sequences was con®rmed by PCR with exon 1-speci®c primers (see Materials and methods). We have recently observed that the 172-kb BAC genomic clone RG253B13 (Genbank accession no. AC002080) that contains exons 1 through 9 of the MET gene can also stain the minichromosomes, yielding smaller, more de®ned signals that are superimposable with the spots generated by YAC 746H5 (data not shown).
Southern blotting analyses established the presence of one to two additional copies of the MET and WNT-2 genes, on average, in whole genomic DNA from the papillary RCC tumour cells examined. This technique turned out to be suciently sensitive to measure relatively small variations in gene copy numbers, provided that signal intensity values are expressed as the mean of duplicate samples for each cell DNA and corrected with reference to an internal standard present Figure 3 Determination of MET and WNT-2 gene copy numbers in RCC tumour cells. DNA (10 mg) was digested with the restriction endonuclease EcoRI, electrophoresed in a 0.7% agarose gel and transferred to a nylon membrane. The Southern blot was ®rst hybridized simultaneously with probes pmetD and BK4, speci®c for the MET and FGF-3 genes, respectively (top panel). After stripping, the blot was rehybridized with probe H2.3A, speci®c for WNT-2 (bottom panel). The gel was loaded with two successive series of duplicate samples and only the left half of the autoradiographs is shown here. DNA sizes (in kilobases) were determined by comparison with a DNA marker run in a parallel lane, from a photograph of the ethidium bromide-stained gel taken prior to the transfer (not shown). DNA from diploid ICIG-7 human ®broblasts, was included as a standard at two copies per cell. By comparison with the perfectly diploid ICIG-7 ®broblast line, the copy number of the 7q31 region determined for the control RCC-41 P2 tumour cells was quite close to that obtained by direct counting of FISH signals on 100 metaphases (1.65 versus 1.61; see Table 1 ). Although the dierence is not statistically signi®cant taking into account the magnitude of the standard deviations, the mean value of FISH signal numbers was always found to be slightly higher than that of the copy numbers determined by Southern blotting in the cells from the four tumours RCC-1 P6 (4.83 versus 4.23), RCC-43 (4.48 versus 3.25), RCC-47 (4.08 versus 3.43) and . This discrepancy could be a consequence of the heterogenous distribution of the t(7;2;7) derivative chromosomes in the case of RCC-1 P6 and of the minichromosomes in the case of the three other tumours (see footnotes to Table 1 ). Thus, one explanation for this discrepancy could be that, since FISH signals are counted on metaphasic (i.e. actively dividing) cells, their number may have been overestimated, if one considers the possibility that the presence of additional chromosome 7 derivatives, each bearing on average two copies of the MET gene, confers a proliferative advantage on the cells that harbour them.
The heterogeneity of the minichromosome distribution could be related to a peculiarity of their structure. Indeed, although these minichromosomes appear to be endowed with a centromere as illustrated in Figure 2 , they were found devoid of any detectable telomeric sequences upon FISH analysis with a probe speci®c to the telomeric region of all human chromosomes (data not shown). Since telomeres are necessary to insure the integrity of chromosome ends, it is possible that the minichromosomes have adopted a ring structure (Blackburn, 1991; Haaf et al., 1992) . Such a structure might lead to segregation anomalies at the time of anaphase and result in an uneven distribution between daughter cells. Loss of the minichromosomes would ensue, unless the maintenance of the expression of a gene (such as MET) above a minimal threshold be mandatory for proliferation of the cells to proceed. A dynamic equilibrium would follow with, as observed, a random distribution of the minichromosomes, centred on a number corresponding to the optimal gene expression level at which the cells will continue to grow. Actually, this number (leading to the maintenance of, on average, three to four copies of the MET gene per cell) is in good agreement with the presence of a trisomy or tetrasomy 7 previously reported for the vast majority of primary papillary renal carcinomas (Kovacs et al., 1991; Kovacs, 1993b; Zbar and Lerman, 1998) .
Interestingly, the MET gene was found to be overexpressed by Northern blotting in the cells from all of the tumours with additional copies of the 7q31 region, as compared to those from the control RCC-41 P2 tumour. The level of expression was essentially the same for all of them, suggesting that a critical threshold has to be reached and maintained for these cells to proliferate. Notably, the cells from the two xenografted tumours (nuclear grade 3 ± 4; see (Glukhova et al., 1998) had a MET gene copy number and a steady-state mRNA level similar to those of the cells from the corresponding initial tumours (grade 1 ± 2). Thus, although the MET gene is likely required for the maintenance of the tumorigenic phenotype, it does not participate in tumour progression by a further increase in expression. Tumour progression may actually involve other genetic loci, as suggested by the presence of additional cytogenetic abnormalities in the cells from xenografted tumours (Glukhova et al., 1998) .
The MET proto-oncogene encodes the transmembrane tyrosine kinase receptor for the hepatocyte growth factor/scatter factor (HGF/SF) and transduces Figure 3 were scanned with the aid of a Bio-imaging Analyser. Signal intensities of the fragments detected with each of the three indicated probes (pmetD, pmetH and H2.3A) were corrected for variations in DNA loading, using as a reference the FGF-3-speci®c signal in each corresponding lane. The results are expressed as the average values (+s.d.) of the MET and WNT-2 copy number calculated from duplicate cell DNA samples for each tumour, after normalization to the DNA from ICIG-7 diploid ®broblasts used as an internal standard. The mean of the values obtained with the three probes is also shown. The last column displays the copy number of the 7q31 region (mean+s.d.), estimated from the number of signals detected by FISH on 100 metaphases from ®ve out of the six RCC tumours, using YAC 746H5 as a probe. ND: not determined.
b
At the time of analysis, the RCC-1 cell culture exhibited 66% tumour cells and 34% contaminating ®broblasts. This explains why the mean copy number of the MET and WNT-2 genes is lower than that determined for RCC-1 P6, from which contaminating normal cells have been eliminated during xenografting.
c In the RCC-1 P6 tumour cell culture, 59% of the cells had a single t(7;2;7) derivative and 41% had two such derivatives, in addition to the two normal chromosomes 7 (i.e. four and six copies of the 7q31 region, respectively). In the RCC-43 tumour cell culture, 93% of the cells had 1 ± 2 der(7) minichromosomes, in addition to two normal chromosomes 7. e The RCC-47 tumour cell culture was composed of a complex mixture of cell populations: at the time of analysis, 31% of the cells had two normal chromosomes 7 (29% contaminating normal ®broblasts plus 2% tumour cells), 6% had three and 31% had four, without any minimichrosome. In addition, 5% of the cells had two chromsomes 7 and 1 ± 4 der(7) minichromosomes, 23% had three chromosomes 7 and 1 ± 3 minichromosomes and 3% had four chromosomes 7 and 1 ± 3 minichromosomes. The minor tumour cell clone with two normal chromosomes 7 and 1 ± 4 der(7) minichromosomes was selected for during xenografting leading to the more homogeneous RCC-47 P3 cell population. f In the RCC-47 P3 tumour cell culture, 65% of the cells had 1 ± 4 der(7) minichromosomes, in addition to two normal chromosomes 7.
g The control RCC-41 P2 cell culture derived from an undierentiated renal tumour was aneuploid. 15% of the cells had one normal chromosome 7, 70% had two, 2% had four and 13% had none. h ICIG-7 normal human ®broblasts, that are perfectly diploid, were used as a reference to calculate gene copy numbers morphogenic, motility and proliferation signals in epithelial cells (for a recent review, see Bardelli et al., 1997) . HGF/SF is normally expressed in ®broblasts from mesenchymal tissues, but anomalous derepression of the gene in epithelial tumour cells cannot be excluded. We have looked for the expression of HGF/SF at the mRNA level by Northern blotting in the cells from our panel of RCC tumours, but could not detect any (data not shown). Thus, activation of the MET receptor does not occur through an autocrine loop. Accumulation of the normal receptor at the cell membrane due to overexpression of the gene could be sucient to chronically trigger the downstream signalling cascade leading to cell proliferation and tumorigenicity. Under such conditions, activation of the accumulated receptor may be further stimulated in vivo by the endogenous HGF/SF secreted by stromal cells surrounding the tumour. Finally, constitutive activation of the MET receptor could be the consequence of a mutagenic event. Indeed, point mutations located in the tyrosine kinase domain of the MET gene have recently been identi®ed in the germline of aected members of families with hereditary papillary renal tumours and in a subset of sporadic papillary RCCs (Schmidt et al., 1997; Fischer et al., 1998; Zbar and Lerman, 1998) . Moreover, it has been shown that the mutant allele was duplicated and overexpressed (with regard to the normal allele) in the tumours with a trisomy 7 that have been analysed (Fischer et al., 1998; Zhuang et al., 1998) . Somatic mutations in MET appear to be infrequent, having been detected in the tumours of only three out of 60 patients with sporadic papillary RCC studied by Schmidt et al. (1997) . Thus, the probability that the MET gene is mutated in all of our tumours ought to be low. Future work will be aimed at elucidating the role played by MET in our sporadic papillary RCCs, ®rst by looking for the possible presence of mutations in the tyrosine kinase domain. This cellular material, cytogenetically well characterized and that can be easily manipulated experimentally, should be useful to investigate the mechanisms of activation of the MET gene. Other molecular events occurring during tumour initiation and/or progression should also be amenable to analysis by comparing the cells from the xenografted tumours with those from the corresponding initial tumours.
Materials and methods
Cell cultures
The isolation and growth in short-term culture of cells from the metastatic sporadic papillary tumours RCC-1, RCC-43 and RCC-47 and from their xenografts serially transplanted into severe combined immunode®cient (SCID) mice (Angevin et al., 1999) has been described previously (Glukhova et al., 1998) . RCC-1 and RCC-43 cells were isolated from metastatic lesions and RCC-47 cells from a primary tumour. All three tumours exhibited typical cytogenetic characteristics of the papillary subtype irrespective of their histologic features (Glukhova et al., 1998) . RCC-1 P6, RCC-43 P5 and RCC-47 P3 cells were isolated from the corresponding xenografted tumours, Pn indicating the number of serial passages in SCID mice. RCC-41 P2 cells, used as a control, were isolated from a xenografted, undierentiated renal tumour. All these cells were used at early in vitro passages (three to 12) after their isolation in culture. ICIG-7 cells are human diploid ®broblasts with a limited in vitro life-span that were derived from embryonic lung (Macieira-Coelho and Azzarone, 1982).
Microdissection and reverse painting with minichromosome-specific probes
Microdissection of the minichromosomes from cells of the RCC-43 P5 and RCC-47 P3 tumours and generation of probes for reverse painting were carried out essentially as previously described (Chudoba et al., 1996) . In order to de®ne the smallest region of chromosome 7 common to the minichromosomes from both tumours, two minichromosomespeci®c painting probes detectable with dierent¯uoro-chromes were prepared: the RCC-43-speci®c probe was labelled with digoxigenin-11-dUTP (Boehringer Mannheim GmbH, Mannheim, Germany) and detected with antidigoxigenin-rhodamine (Dianova GmbH, Hamburg, Germany), whereas the RCC-47 speci®c one was labelled with biotin-16-dUTP (Boehringer Mannheim) and detected with avidin-FITC (Vector Lab, Burlingame, CA, USA). Reverse painting was carried out by hybridizing simultaneously both minichromosome-speci®c probes to chromosomes from normal cells. 
YAC probes
In order to locate more precisely the site of the overlapping region, two nonchimeric YACs mapping to the 7q31 region, 746H5 (7q31.2 ± 31.3, D7S486-D7S522) and 880B6 (7q31.3 ± 32.1, D7S680 ± D7S686) were obtained from the library of the Centre d'Etude du Polymorphisme Humain (CEPH, Paris, France). YAC DNA was prepared and labelled with biotin-16-dUTP as described (Goguel et al., 1996) . YAC 965F1 is an unrelated YAC used as a negative control for PCR.
Fluorescence in situ hybridization (FISH) with centromeric and YAC probes A chromosome 7 centromeric probe was obtained from Vysis, Inc. (Downers Grove, IL, USA). Signal detection was performed according to the manufacturer's instructions. Alu-PCR YAC probes (200 ng) were denatured at 808C for 5 min and preannealed for 2 h at 378C with a 50-fold excess of both Cot-1 DNA (Life Technologies, Gaithersburg, MD, USA) and DNA from human placenta (Sigma, St. Louis, MO, USA). Hybridization and avidin anti-avidin detection were performed as described previously (Slim et al., 1994) .
Presence of MET proto-oncogene sequences in YAC 746H5
Based on the physical map published by Lin et al. (1996) , YAC 746H5 would be expected to overlap the MET protooncogene locus. In order to con®rm the presence of MET sequences in this YAC, PCR was carried out with primers speci®c for the exon 1 of the gene: forward primer: 5'-ATCAACTCATTAGCTGTGGCAGCGTCA; reverse primer: 5'-AGAGTTTCCCTTTGGACCGTCAAGAAGTA.
Ampli®cation was carried out using a Hybaid TM thermocycler (Hybaid, Ltd., Ashford, Middlesex, UK), in a total volume of 50 ml containing 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM MgCl 2 , 0.01% gelatine, 0.2 mM each of the four dNTPs, 1.25 U AmpliTaq DNA polymerase (Perkin Elmer/ Cetus, Norwalk, CT, USA) and 200 ng of DNA extracted from yeast strains containing YAC 746H5 or the control YACs 880B6 and 965F1. DNA samples were denatured at 948C for 10 min and ampli®ed by 40 cycles of denaturation at 948C for 45 s, annealing at 688C for 3 min and extension at 728C for 3 min. Aliquots of the PCR reactions were analysed by electrophoresis through a 1.5% NuSieve GTG gel (FMC Bioproducts, Rockland, ME, USA) and DNA fragments visualized by ethidium bromide staining. A fragment of the expected size (424 bp) was found to be uniquely ampli®ed when 746H5, but not 880B6 or 965F1, DNA was used as a template. The authenticity of this fragment was con®rmed by digestion with the DdeI and TaqI restriction enzymes (data not shown). In both cases, the digestion pro®le was in agreement with that predicted from the published cDNA sequence (Genbank accession no. J02958).
Extraction of cellular DNA and RNA
Tumour cells were seeded into 10 Petri dishes (10-cm diameter) at a density of 10 6 to 2610 6 cells per dish containing 10 ml of culture medium. The medium was changed after 3 to 4 days of incubation at 378C in air-5% CO 2 . Twenty-four hours later, cells were scraped with a rubber policeman, harvested on ice and washed twice with cold phosphate-buered saline (PBS). The last cell suspension was divided into two 15-ml conical tubes, one each for the extraction of DNA and RNA, respectively. Cell pellets were quickly frozen on dry ice and kept at 7808C until use. Genomic DNA was prepared using the <salting out> procedure described by Miller et al. (1988) adapted to cultured cells. Brie¯y, cells were resuspended in 3 ml of 10 mM Tris-HCl, pH 8.0, 0.4 M NaCl, 2 mM EDTA and, while vortexing, 0.5 ml of proteinase K (1 mg/ml) and 0.2 ml of 10% sodium dodecyl sulphate (SDS) were successively added dropwise. The resulting viscous lysate was incubated at 378C overnight. The SDS and residual protein were precipitated by adding 1 ml of a saturated NaCl solution and vigorously shaking the tube by hand for 15 ± 20 s. After centrifugation at 3000 r.p.m. for 15 min at room temperature, the supernatant was supplemented with 2 volumes of ethanol and the DNA was precipitated by gently inverting the tube several times. The precipitate was collected with a plastic tip, rinsed in 70% ethanol, dried under vacuum and redissolved in 2.8 ml of 10 mM Tris-HCl, pH 8.0, 1 mM EDTA (TE) containing 50 mg/ml of RNAse A. After incubation at 378C for 6 h, the salt concentration was adjusted to 0.15 M by adding 0.24 ml of a 5 M NaCl solution and the proteinase K-SDS treatment and <salting out> procedure were repeated as described above up to the ethanol precipitation step. The precipitated DNA was transferred with a plastic tip into a 1.5-ml microfuge tube containing 1 ml of 70% ethanol. After centrifugation at 15 000 r.p.m. for 5 min, the pellet was dried under vacuum and dissolved in 200 ml of TE buer. The concentration was determined from the optical density at 260 nm and adjusted to 1 mg/ml. Extraction of total cellular RNA was carried out essentially according to the method described by Chomczynski and Sacchi (1987) , except that the ®nal RNA precipitate was rinsed twice with 75% ethanol before drying under vacuum. The dry pellet was redissolved in 200 ml of RNAse-free H 2 O and the RNA concentration determined from the optical density at 260 nm.
Southern and Northern blot analyses
Aliquots (10 mg each) of EcoRI-digested cell DNA were fractionated by electrophoresis through 0.7% agarose gels. A mixture of 1 mg of`1 kb DNA ladder' and 500 ng of HindIIIdigested l DNA (both from Life Technologies), preheated at 658C for 5 min, was run in parallel in the left-most lane as a size marker. Depurination and denaturation of the DNA were achieved by successively treating the gel twice for 10 min with 0.25 N HCl and twice for 15 min with 0.5 N NaOH, 1.5 M NaCl. The DNA was then transferred by capillarity onto a neutral nylon membrane (Hybond N, Amersham Pharmacia Biotech, Uppsala, Sweden) for 2 ± 3 h, using the 0.5 N NaOH, 1.5 M NaCl solution. After a quick wash in 26 SSPE (16 SSPE is 0.18 M NaCl, 10 mM sodium phosphate, pH 6.8, 2 mM EDTA), the membrane was airdried and the DNA was immobilized by UV irradiation. Cell RNA samples (10 mg each) were denatured by heating for 10 min at 688C in the presence of 2.2 M formaldehyde and 50% formamide and immediately loaded onto a 1% agarose gel containing 2.2 M formaldehyde (Sambrook et al., 1989) . After two 15-min treatments with 50 mM NaOH, 10 mM NaCl, the gel was equilibrated with 150 mM ammonium acetate, stained with ethidium bromide (1 mg/ml), destained and the RNA transferred onto a neutral nylon membrane (Hybond N, Amersham Pharmacia Biotech), essentially as described by Dautry et al. (1988) . Hybridization was carried out as previously described (Galdemard et al., 1995) . DNA fragments to be used as probes were excised from recombinant plasmids by digestion with the appropriate enzyme(s), gel-puri®ed and radiolabelled by the random priming method (Multiprime DNA labelling system, Amersham Pharmacia Biotech) in the presence of [a-32 P]dCTP (NEN TM Life Science Products, Boston, MA, USA) to a speci®c activity of 1 to 3610 9 c.p.m. per mg. The probes used for Southern blotting were: two genomic DNA fragments from the MET gene, namely, the 1.2-kb EcoRI and the 1.3-kb EcoRI-SalI inserts from plasmids pmetD and pmetH, respectively (Park et al., 1986) ; for the WNT-2 gene, a 2.3-kb HindIII fragment excised from plasmid H2.3A (Rommens et al., 1989) and for the FGF-3 gene, the 1.0-kb BamHI-KpnI insert from plasmid BK4 (Casey et al., 1986) . The probes used for Northern blotting were: a 1.3-kb EcoRI fragment of MET cDNA from plasmid pHOS-1 (Park et al., 1987) and a 1.1-kb SmaI ± BamHI fragment from the mouse b-actin cDNA insert of plasmid pAL41 (Minty et al., 1983) . The relative intensity of the positive signals detected on the blots was determined using a Bio-imaging Analyser BAS 1000 and the MacBas 2.2 software (Fuji Photo Film Co., Ltd., Japan).
